No Data
No Data
Microba Life Sciences Ltd: Microba receives $6 million R&D Tax Incentive Refund
Microba Life Sciences Ltd: Annual Report to Shareholders
Microba Life Sciences Ltd: Details of Q1 FY25 Quarterly Report, Appendix 4C & Webinar
Clinical Microbiomics A/S Announces New Deal With Microba Life Sciences Ltd's and Prepares to Launch New Company Brand in November 2024
Analysts Expect Breakeven For Microba Life Sciences Limited (ASX:MAP) Before Long
Microba Life Sciences Agrees to Transfer Research Services Business to Clinical Microbiomics
No Data
No Data